CME Group Inc. (NASDAQ: CME) operates the world’s largest derivatives marketplace, spanning interest rates, equities, commodities, and digital assets. Shares recently traded around $276 per share, giving the company a market value of roughly $100.4B.
CME Group runs a capital-light, highly profitable business supported by strong margins and recurring transaction activity. Looking at who owns CME Group and recent insider trades helps show how large investors and company leadership appear to be approaching the stock today.
Who Are CME Group’s Top Shareholders?
CME Group’s shareholder base is led by large institutional investors that typically hold through market cycles, which can help keep long-term ownership stable. Recent filings show active managers adjusting exposure in both directions.
- The Vanguard Group: 35,141,061 shares (9.75%), ~$9.78B value. Added 126,983 shares (+0.36%).
- BlackRock Institutional Trust: 19,428,747 shares (5.39%), ~$5.41B value. Added 274,444 shares (+1.43%).
- State Street Investment Management: 16,087,800 shares (4.46%), ~$4.48B value. Cut 331,396 shares (-2.02%).
- Geode Capital Management: 9,378,391 shares (2.60%), ~$2.61B value. Added 199,710 shares (+2.18%).
- Capital World Investors: 8,271,156 shares (2.29%), ~$2.30B value. Cut 345,412 shares (-4.01%).
- J.P. Morgan Asset Management: 6,860,367 shares (1.90%), ~$1.91B value. Cut 1,711,417 shares (-19.97%).
- T. Rowe Price Associates: 6,819,629 shares (1.89%), ~$1.90B value. Added 1,593,828 shares (+30.50%).
These holdings show CME Group remains anchored by passive institutions, while active managers are repositioning based on valuation and portfolio preferences, which for investors suggests stability at the core with mixed views at the margin.
Hedge Fund Highlights
One notable move last quarter came from Balyasny Asset Management, founded by Dmitry Balyasny, which sharply increased its exposure to CME Group. The position grew by a large percentage to a meaningful dollar value, which appears to reflect a more constructive view on CME Group’s long-term earnings durability.
Another standout was Hudson Bay Capital Management, led by Sander Gerber, which boosted its CME Group stake by over 3,000% to roughly $9M value. While the position remains small in absolute terms, the scale of the increase stands out following recent share price consolidation.
Horizon Kinetics Asset Management, founded by Murray Stahl, also raised its CME Group holdings by more than 100%, bringing its position to roughly $75M value, which may suggest confidence in the company’s asset-light structure and cash flow consistency.
Meanwhile, Gotham Asset Management, run by Joel Greenblatt, increased its CME Group position by about 41% to approximately $47M value, a move that appears consistent with Gotham’s valuation-focused approach, and for investors highlights selective accumulation rather than broad hedge fund consensus.
Taken together, hedge fund activity around CME Group appears selective rather than one-sided. Several managers meaningfully increased exposure, while others remained on the sidelines, which for investors suggests growing interest in CME Group’s earnings durability and cash flow profile, but not a broad shift toward aggressive positioning at current price levels.
Track the top shareholders of over 50,000 global stocks (It’s free) >>>
CME Group’s Recent Insider Trades
Insider trades can provide context on how executives and directors may be managing personal exposure. Recent filings for CME Group show several small transactions that lean toward selling.
- Terrence A. Duffy (Officer & Director): Sold shares worth roughly $6.6M across two trades at prices around $269 to $270.
- Derek Louis Sammann (Officer): Sold shares totaling about $2.0M near $275.
- Harold Eugene Ford Jr. (Director): Sold approximately $264K worth of shares.
- Hilda Harris Piell (Officer): Sold shares worth roughly $330K across two transactions.
- Kendal L. Vroman (Officer): Sold approximately $85K worth of shares.
These transactions are small relative to CME Group’s overall share base and do not materially change insider ownership, but for investors they suggest leadership appears cautious at current price levels.
See recent insider trade data for over 50,000 global stocks (It’s free) >>>
What the Ownership & Insider Trade Data Tell Us
CME Group’s ownership remains dominated by large institutions that appear comfortable holding the stock through cycles. Hedge fund activity points to selective buying rather than broad agreement, while insider trades lean modestly toward selling.
Taken together, the data suggests a measured tone. CME Group continues to be treated as a high-quality, cash-generating business, but both insiders and some active managers appear mindful of valuation, which for investors may indicate more balanced expectations following recent gains.
Value Any Stock in Under 60 Seconds (It’s Free)
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
